Table 2.
Obstetric results.
| Controls A | Mild preeclampsia B | Severe preeclampsia C | P-value | ||
|---|---|---|---|---|---|
| (n=24) | (n=32) | (n=32) | |||
| n (%) | n (%) | n (%) | |||
| Mode of delivery | NSVD | 12 (50)C | 14 (43.8)C | 6 (18.8) | 0.022 |
| C/S | 12 (50) | 18 (56.3) | 26 (81.3)A,B | ||
| IUGR | Absent | 24 (100)B,C | 15 (46.9) | 17 (53.1) | <0.001 |
| Present | 0 (0) | 17 (53.1)A | 15 (46.9)A | ||
| Uterine resistance increase | Absent | 24 (100)B,C | 11 (34.4) | 9 (28.1) | <0.001 |
| Present | 0 (0) | 21 (65.6)A | 23 (71.9)A | ||
| NICU admission | Absent | 24 (100)B,C | 17 (53.1) | 11 (34.4) | <0.001 |
| Present | 0 (0) | 15 (46.9)A | 21 (65.6)A | ||
Fisher Freeman Halton test (Monte Carlo); A – significant compared with the control group; B – significant compared with the mild preeclampsia group; C – significant compared with the severe preeclampsia group; NSVD – normal spontaneous vaginal delivery; C/S – cesarean section; IUGR – intrauterine growth restriction; NICU – Nwborn Intensive Care Unit.